These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 25090991)

  • 1. New insights on the risk for cardiovascular disease in African Americans: the role of added sugars.
    Saab KR; Kendrick J; Yracheta JM; Lanaspa MA; Pollard M; Johnson RJ
    J Am Soc Nephrol; 2015 Feb; 26(2):247-57. PubMed ID: 25090991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults.
    Mukamal KJ; Tremaglio J; Friedman DJ; Ix JH; Kuller LH; Tracy RP; Pollak MR
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):398-403. PubMed ID: 26634651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.
    Gutiérrez OM; Judd SE; Irvin MR; Zhi D; Limdi N; Palmer ND; Rich SS; Sale MM; Freedman BI
    Nephrol Dial Transplant; 2016 Apr; 31(4):602-8. PubMed ID: 26152403
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Chen TK; Appel LJ; Grams ME; Tin A; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
    Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1765-1769. PubMed ID: 28572159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOL1 Gene Kidney Risk Variants and Cardiovascular Disease: Getting to the Heart of the Matter.
    McLean NO; Robinson TW; Freedman BI
    Am J Kidney Dis; 2017 Aug; 70(2):281-289. PubMed ID: 28143671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Apolipoprotein L1 Gene and Cardiovascular Disease.
    Robinson TW; Freedman BI
    Methodist Debakey Cardiovasc J; 2016; 12(4 Suppl):2-5. PubMed ID: 28298955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
    Chen TK; Choi MJ; Kao WH; Astor BC; Scialla JJ; Appel LJ; Li L; Lipkowitz MS; Wolf M; Parekh RS; Winkler CA; Estrella MM; Crews DC
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2128-35. PubMed ID: 26430087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein L1 and Kidney Disease in African Americans.
    Friedman DJ; Pollak MR
    Trends Endocrinol Metab; 2016 Apr; 27(4):204-215. PubMed ID: 26947522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume.
    Freedman BI; Gadegbeku CA; Bryan RN; Palmer ND; Hicks PJ; Ma L; Rocco MV; Smith SC; Xu J; Whitlow CT; Wagner BC; Langefeld CD; Hawfield AT; Bates JT; Lerner AJ; Raj DS; Sadaghiani MS; Toto RD; Wright JT; Bowden DW; Williamson JD; Sink KM; Maldjian JA; Pajewski NM; Divers J
    Kidney Int; 2016 Aug; 90(2):440-449. PubMed ID: 27342958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.
    Freedman BI; Langefeld CD; Murea M; Ma L; Otvos JD; Turner J; Antinozzi PA; Divers J; Hicks PJ; Bowden DW; Rocco MV; Parks JS
    Nephrol Dial Transplant; 2011 Nov; 26(11):3805-10. PubMed ID: 21931123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.
    Freedman BI; Kopp JB; Langefeld CD; Genovese G; Friedman DJ; Nelson GW; Winkler CA; Bowden DW; Pollak MR
    J Am Soc Nephrol; 2010 Sep; 21(9):1422-6. PubMed ID: 20688934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APOL1 and nephropathy progression in populations of African ancestry.
    Freedman BI
    Semin Nephrol; 2013 Sep; 33(5):425-32. PubMed ID: 24119848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-based risk assessment of APOL1 on renal disease.
    Friedman DJ; Kozlitina J; Genovese G; Jog P; Pollak MR
    J Am Soc Nephrol; 2011 Nov; 22(11):2098-105. PubMed ID: 21997396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension-misattributed kidney disease in African Americans.
    Skorecki KL; Wasser WG
    Kidney Int; 2013 Jan; 83(1):6-9. PubMed ID: 23271482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOL1 and kidney disease: new insights leading to novel therapies.
    Freedman BI
    Am J Kidney Dis; 2015 Jul; 66(1):9-11. PubMed ID: 26111904
    [No Abstract]   [Full Text] [Related]  

  • 16. APOL1 and kidney disease.
    Pollak MR; Genovese G; Friedman DJ
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):179-82. PubMed ID: 22257798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Target organ damage in African American hypertension: role of APOL1.
    Freedman BI; Murea M
    Curr Hypertens Rep; 2012 Feb; 14(1):21-8. PubMed ID: 22068337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy.
    Divers J; Núñez M; High KP; Murea M; Rocco MV; Ma L; Bowden DW; Hicks PJ; Spainhour M; Ornelles DA; Kleiboeker SB; Duncan K; Langefeld CD; Turner J; Freedman BI
    Kidney Int; 2013 Dec; 84(6):1207-13. PubMed ID: 23677244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased burden of cardiovascular disease in carriers of APOL1 genetic variants.
    Ito K; Bick AG; Flannick J; Friedman DJ; Genovese G; Parfenov MG; Depalma SR; Gupta N; Gabriel SB; Taylor HA; Fox ER; Newton-Cheh C; Kathiresan S; Hirschhorn JN; Altshuler DM; Pollak MR; Wilson JG; Seidman JG; Seidman C
    Circ Res; 2014 Feb; 114(5):845-50. PubMed ID: 24379297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.
    Anyaegbu EI; Shaw AS; Hruska KA; Jain S
    Pediatr Nephrol; 2015 Jun; 30(6):983-9. PubMed ID: 25530085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.